AZAneta Zwierzchowska

Aneta Zwierzchowska

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aneta Zwierzchowska has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Targeted Methotrexate Treatment in Cesarean Scar Pregnancy: A Case Report and Literature Review

    by Marta Adamczyk, Helena Limowska, Aneta Zwierzchowska, Piotr Merks, Ewa Barcz

    Introduction: Cesarean scar pregnancy (CSP) represents a rare form of ectopic pregnancy, though its incidence is expected to rise in countries with rising rates of deliveries by cesarean section (CS). Delayed diagnosis and treatment can result in uterine rupture and hemorrhage. Diagnosis is based on transvaginal ultrasonography (TVUS). No standardized treatment protocol for CSP has been established; however, local ultrasound‐guided methotrexate (MTX) injection into the gestational sac (GS) is widely recognized as a highly effective therapy. Case Report: A 38‐year‐old woman with a history of CS 2 years prior was admitted to the hospital due to moderately heavy vaginal bleeding that had started 4 days before. Her general condition was assessed as stable. The last menstrual period occurred 6 weeks and 2 days earlier. A β ‐hCG test performed on presentation showed a level of 10,775 mIU/mL. TVUS revealed a GS measuring 8.6 mm located within the CS scar, containing a yolk sac and an embryo with a CRL of 2.8 mm. Cardiac activity had not been detected. A diagnosis of CSP was made. Other laboratory tests showed no abnormalities. On the following day, the β ‐hCG level had increased to 13,001 mIU/mL. Under TVUS guidance, 80 mg of MTX was injected into the GS. Following days showed a gradual decline in β ‐hCG levels, reaching 927.77 mIU/mL on the third day postprocedure. A follow‐up TVUS revealed no visible GS. The patient remained in stable condition and was discharged from the hospital. On Day 10 postprocedure, the β ‐hCG level had decreased to 62.04 mIU/mL. Aside from mild uterine bleeding, the patient reported no other complaints. Conclusions: In the presented case, early detection followed by timely ultrasound‐guided MTX injection into the GS achieved complete resolution without requiring additional interventions, highlighting its potential as a safe and effective conservative approach when CSP is diagnosed early.

  • Open Access

    Sonography as a Diagnostic Tool in Midurethral Sling Complications: A Narrative Review

    by Aneta Zwierzchowska, Paweł Tomasik, Edyta Horosz, Ewa Barcz

    Despite the established safety and efficacy of midurethral slings (MUS), which are the current gold standard treatment for stress urinary incontinence (SUI), the potential for postoperative complications remains a significant concern for both healthcare professionals and patients. Meanwhile, sonography has emerged as a significant diagnostic tool in urogynecology, and one of the applications of this imaging modality may be the evaluation of complications arising from MUS procedures. This review, based on a comprehensive literature search, focuses on the use of pelvic floor ultrasound (US) in the context of MUS complications. It includes analyses of randomized controlled trials, prospective, and retrospective studies, covering preoperative and postoperative investigations, to assess complications such as persistent and recurrent SUI, urinary retention and obstructive voiding, de novo urgency/overactive bladder, vaginal exposure, sling erosion, pain, and hematoma. The review critically examines the existing literature, with a particular focus on recent publications. Despite the variability in findings, it appears that for each of the discussed complications, the application of pelvic floor US can significantly support the diagnostic and therapeutic process. The paper also identifies potential future directions for the development of US applications in diagnosing MUS complications.


  • Open Access

    The Influence of Successful Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse on Depression, Anxiety, and Insomnia—A Prospective Intervention Impact Assessment Study

    by Urszula Kalata, Michał Jarkiewicz, Andrzej Pomian, Aneta Janina Zwierzchowska, Edyta Horosz, Wojciech Majkusiak, Beata Rutkowska, Ewa Monika Barcz

    Introduction: The association between pelvic floor disorders (PFDs) and psychiatric conditions is an area of emerging interest. The causal direction of this relationship, however, remains ambiguous; it is unclear whether PFDs directly contribute to the deterioration of mental health or if pre-existing psychiatric conditions such as depression exacerbate the symptoms of PFDs. This study aimed to evaluate the effects of successful surgical treatment for stress urinary incontinence (SUI) and pelvic organ prolapse (POP) on symptoms of depression, anxiety, and insomnia. Materials and Methods: This investigation focused on patients who underwent successful surgical interventions for SUI and POP. Both subjective and objective symptoms of PFDs, along with psychiatric status, were assessed before and after the surgical procedures. Results: This study found that successful surgical treatment of SUI and POP led to a significant reduction in anxiety scores. Additionally, in patients with SUI, successful treatment was objectively associated with a decrease in the severity of insomnia. Alleviation of symptoms associated with the lower urinary tract, prolapse, and colorectal–anal region following POP surgery was correlated with improvements in depression and anxiety but not insomnia. Subjectively assessed improvements in SUI subjective symptoms were linked to reductions in the severity of depression, anxiety, and insomnia in patients who underwent anti-incontinence surgery. Conclusions: These findings suggest a potential cause-and-effect relationship between PFDs and certain psychiatric disorders, highlighting the importance of successful treatment of PFDs in mitigating symptoms of depression, anxiety, and insomnia.


  • Open Access

    Demographic risk factors for mid-urethral sling failure. Do they really matter?

    by Wojciech Majkusiak, Andrzej Pomian, Edyta Horosz, Aneta Zwierzchowska, Paweł Tomasik, Wojciech Lisik, Ewa Barcz

    Age, obesity and vaginal deliveries (VD) are recognized risk factors for stress urinary incontinence (SUI). According to many authors, the abovementioned risk factors for incontinence also increase the risk of mid-urethral sling (MUS) failure. Our aim was to evaluate the objective and subjective effectiveness of retropubic MUS in 12 months observation, relative to the three potential risk factors of failure: obesity, age and VDs. A prospective observational study including 238 women who underwent retropubic MUS implantation was performed. Patients were divided into subgroups: obese vs non-obese, Significant improvement in the pad test was observed in all patients (83.2 ± 78.6 g vs 0.7 ± 3.3 g). Negative cough test results were obtained in over 94% of patients. Significant improvement in the IIQ7 results was observed in all patients (74.2 ± 17.7 vs 5.5 ± 13.4). No significant differences in all the analyzed parameters with regard to BMI, age and parity were observed. No combination of risk factors influenced the objective and subjective cure rates. Our study demonstrated that older age, obesity and history of VDs have no impact on objective and subjective sling effectiveness in a short term observation. There is no influence of combined demographic features on the failure risk.


    • 1 October 2012
      • Vol. 83  (10) , 760-5

    [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].

    by Aneta Zwierzchowska, Michał Głuszak, Zoulikha Jabiry-Zieniewicz, Agnieszka Banaszek-Wysoczańska, Wojciech Dziadecki, Ewa Barcz

    The aim of our study was to assess the efficacy and safety of medical treatment of non-viable first trimester pregnancy. We analyzed 50 cases of women diagnosed with non-viable first trimester pregnancy: missed abortion (79.6%) or anembryonic pregnancy (20.4%), who were admitted and treated at the First Clinic of Obstetrics and Gynecology Medical University of Warsaw, between June 2011 and February 2012. The diagnosis was made after two ultrasound examinations, performed at least one week apart. None of the patients manifested symptoms of imminent miscarriage. All women received medical treatment - misoprostol administered vaginally or in cases of excessive bleeding in the course of the procedure, sublingually - according to our own scheme. The patients were informed that any moment they could decide to discontinue medical treatment and ask for surgery Initially, 4 tablets containing misoprostol (800 mcg) were administered vaginally A control ultrasound examination was performed 6 hours later. If expulsion of the gestational sac was completed, the patient was discharged. If the gestational sac was still present in the uterus, an additional dose of misoprostol was administered: 4 tablets vaginally or if excessive bleeding occurred, 3 tablets (600 mcg) sublingually. Another ultrasound examination was performed after 6 hours from the second dose and the patient was discharged if the expulsion of the gestational sac was completed. If the procedure failed, it was repeated in the same manner the next day. D&C was performed in cases of excessive bleeding, failure of medical treatment after 48 hours, patient decision to discontinue medical treatment or suspected incomplete abortion after menstrual bleeding. For women who completed the medical treatment, control visits were scheduled 14 days after hospital discharge and after menstrual bleeding, if incomplete abortion was suspected. D&C was performed in 12% of patients because of failure of medical treatment after 48 hours, excessive bleeding or incomplete abortion after menstrual bleeding. Additional 6% of women decided to discontinue medical treatment and demanded D&C before completing 48 hours of treatment. The mean dose of misoprostol administered until the expulsion of the gestational sac was 1.404 g (7.02 tablets). In 60% of cases the expulsion was completed before 12 hours from the beginning of the procedure. In multiparae, the time until expulsion did not exceed 6 hours more frequently than in nulliparae (50 vs. 24.14%, p<0.05). The duration of the procedure did not exceed 24 hours in any of the multiparae. Among women who did not undergo D&C, 46.2% were diagnosed with complete abortion during the control visit, 74 days after the hospital discharge, and 53.8%- after menstrual bleeding. No serious side effects of misoprostol, influencing its safety, were observed. Medical treatment is a highly effective and safe method of management of non-viable first trimester pregnancy. Because of the currently existing variety of protocols, it is recommended to implement standard schemes of misoprostol administration and control visits. It seems that there is no need for hospitalization during the procedure. Outpatient care may contribute to further reduction of the D&C rate. Limited surgery rate, apart from decreasing the risk of iatrogenic damage of the uterus, additionally leads to lower treatment costs as it eliminates the necessity of hospitalization and anesthesia.